Associations between adipocyte fatty acid-binding protein and clinical parameters in polycystic ovary syndrome

Archives of Gynecology and Obstetrics

Volumn 291, Issue 2, 2015, Pages 447-450

  Doğanay, Melike ^a   Ozyer, Sebnem Sen ^a   Var, Turgut ^a   Tonguc, Esra ^a   Gun Eryilmaz, Ozlem ^a   Ozer, Irfan ^a   Guzel, Ali Irfan ^a  

^a ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Adipocyte fatty acid binding protein; Metabolic syndrome; Obesity; Polycystic ovary syndrome

Indexed keywords

FATTY ACID BINDING PROTEIN 4; FOLLITROPIN; INSULIN; LUTEINIZING HORMONE; TESTOSTERONE; FATTY ACID BINDING PROTEIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; OBESITY; OVARY POLYCYSTIC DISEASE; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE; ADOLESCENT; BLOOD; BODY WEIGHT; CASE CONTROL STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BODY MASS INDEX; BODY WEIGHT; CASE-CONTROL STUDIES; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84930811097     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-014-3422-2     Document Type: Article

References (21)

1. Carmina E, Lobo RA (1999) Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84:1897–1899
2. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar Morreale HF (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434–2438
3. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yıldız BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745–2749
4. Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333(13):85361
5. Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774–800
6. Legro RS (2002) Polycystic ovary syndrome. Long term sequelae and management. Minerva Ginecol 54:97–114
7. Barber TM, McCarthy MI, Wass JA, Franks S (2006) Obesity and polycystic ovary syndrome. Clin Endocrinol 65:137–145
8. Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, Wat NM, Wong WK, Lam KS (2006) Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 52:405–413
9. Stejskal D, Karpisek M (2006) Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome. Eur J Clin Invest 36:621–625
10. Tuncman G, Erbay E, Hom X, De Vivo I, Campos H, Rimm EB, Hotamisligil GS (2006) A genetic variant at the fatty acid-binding protein ap2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. PNAS 103:6970–6975
11. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47
12. Wang J, Tang J, Wang B, Song J, Liu J, Wei Z, Zhang F, Ma X, Cao Y (2009) FABP4: a novel candidate gene for polycystic ovary syndrome. Endocrine 36(3):392–396
13. Boord JB, Fazio S, Linton MF (2002) Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol 13:141–147
14. Cao H, Maeda K, Gorgun CZ, Kim HJ, Park SY, Shulman Gl, Kim JK, Hotamisligil GS (2006) Regulation of metabolic responses by adipocyte/macrophage: fatty acid-binding proteins in leptin deficient mice. Diabetes 55:1915–1922
15. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867
16. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274:1377–1379
17. Hertzel AV, Smith LA, Berg AH, Cline GW, Shulman GI, Scherer PE, Bernlohr DA (2006) Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice. Am J Physiol Endocrinol Metab 290:E814–E823
18. Hu W, Qiao J (2011) Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome. Endocrine 40(2):196–202
19. Möhlig M, Weickert MO, Ghadamgadai E, Machlitt A, Pfüller B, Arafat AM, Pfeiffer AF, Schöfl C (2007) Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women. Eur J Endocrinol 157(2):195–200
20. Lázaro I, Díaz M, Cabré A et al (2011) Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess. Gynecol Endocrinol 27:935–939
21. Jeon YE, Lee KE, Jung JA et al (2013) Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome. Gynecol Obstet Invest 75:268–274